Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

S&P Biotech SPDR (XBI)

97.09   0.17 (0.18%) 02-14 16:00
Open: 97.12 Pre. Close: 96.92
High: 97.54 Low: 95.99
Volume: 2,051,837 Market Cap: 8536M
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 97.631 - 98.104 98.104 - 98.512
Low: 94.851 - 95.4 95.4 - 95.875
Close: 96.287 - 97.139 97.139 - 97.874

Technical analysis

as of: 2020-02-14 4:33:52 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 114.50     One year: 133.73
Support: Support1: 91.86    Support2: 88.05
Resistance: Resistance1: 98.03    Resistance2: 114.50
Pivot: 94.07
Moving Average: MA(5): 97.14     MA(20): 94.02
MA(100): 88.50     MA(250): 86.60
MACD: MACD(12,26): 0.90     Signal(9): 0.37
Stochastic oscillator: %K(14,3): 93.15     %D(3): 93.74
RSI: RSI(14): 58.64
52-week: High: 98.79  Low: 72.97  Change(%): 13.4
Average Vol(K): 3-Month: 505411  10-Days: 378163

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
XBI has closed below upper band by 24.3%. Bollinger Bands are 50.3% wider than normal. The large width of the bands suggest high volatility as compared to XBI's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

Biotech Week In Review: XBI Plunges Below 50 Day Moving Average - Jonathan Faison
Surprisingly, ROTY's model account has bucked the trend (so far) as certain catalyst and revaluation ideas play out nicely.

Biotech ETFs Are Not Riding the Wave from Coronavirus Panic
Despite concerns of a spreading coronavirus out of China, biotechnology stocks and sector-related ETFs are not enjoying the usual bump on hopes of developing new treatments to counter the contagion. Among the worst performing non-leveraged ETFs of Friday, the Virtus LifeSci Biotech Clinical Trials ETF (BBC) declined 3.4% and SPDR S&P Biotech ETF (NYSEArca: XBI) […] The post Biotech ETFs Are Not Riding the Wave from Coronavirus Panic appeared first on ETF Trends .

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE Arca
Shares Out. (M) 53.75
Shares Float (M) 53.75
% Held by Insiders
% Held by Institutions
Shares Short (K) 2297
Shares Short P. Month (K)

Stock Financials

Book Value (p.s.) 4.500
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -23.7
Return on Equity (ttm) -19.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)

Stock Valuations

P/E Growth Ratio
P/BV 21.58

Dividends & Splits

Dividend 0.275
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.